OLANZAPINE AND FLUOXETINE HYDROCHLORIDE

Post-LOE

olanzapine and fuoxetine

Pfizer

ANDAORALCAPSULE

Approved

Nov 2012

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

OLANZAPINE AND FLUOXETINE HYDROCHLORIDE (olanzapine and fuoxetine) by Pfizer is indications, is unclear. Approved for depression, depression. First approved in 2012.

Drug data last refreshed 22h ago

Mechanism of Action

indications, is unclear. However, the combined effect of olanzapine and fluoxetine at the monoaminergic neural systems (serotonin, norepinephrine, and dopamine) could be responsible for the pharmacological effect.

Pharmacologic Class:

Atypical Antipsychotic

Indications (1)

depression

Company

Worked on OLANZAPINE AND FLUOXETINE HYDROCHLORIDE at Pfizer? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.